|
|
|
Insider
Information: |
Given Douglas B |
Relationship: |
Director |
City: |
Lincolnshire |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
129,711 |
|
Indirect Shares
|
148,367 |
|
|
Direct
Value |
$3,202,565 |
|
|
Indirect Value
|
$629,595 |
|
|
Total
Shares |
278,078 |
|
|
Total
Value |
$3,832,160 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
10
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
1
|
9
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-47.6%
|
-107.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Corautus Genetics Inc |
VEGF |
Director |
2007-06-05 |
0 |
2007-06-05 |
122,867 |
Premium* |
|
Arrowhead Pharmaceuticals Inc |
ARWR |
Director |
2024-01-11 |
129,711 |
2023-05-05 |
25,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
45 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2020-12-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
31,000 |
15,500 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2020-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
600 |
114,138 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2020-12-17 |
4 |
S |
$79.59 |
$39,795 |
I/I |
(500) |
15,000 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2020-12-17 |
4 |
S |
$79.30 |
$719,648 |
D/D |
(9,075) |
114,738 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2020-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
235 |
113,903 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2020-12-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
35 |
113,868 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2021-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,500 |
123,368 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2021-01-04 |
4 |
S |
$76.08 |
$304,320 |
D/D |
(4,000) |
119,368 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2021-01-15 |
4 |
S |
$83.28 |
$249,840 |
I/I |
(3,000) |
12,500 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2021-02-22 |
4 |
S |
$88.73 |
$99,821 |
I/I |
(1,125) |
13,875 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2021-06-22 |
4 |
S |
$89.21 |
$401,445 |
D/D |
(4,500) |
114,868 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2021-09-09 |
4 |
S |
$65.24 |
$326,200 |
D/D |
(5,000) |
109,868 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2021-12-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
655 |
109,213 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2021-12-28 |
4 |
B |
$66.37 |
$43,472 |
D/D |
655 |
109,868 |
2.39 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,400 |
116,268 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2023-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,867 |
124,135 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2023-02-27 |
4 |
S |
$32.62 |
$28,543 |
I/I |
(875) |
13,000 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2023-05-05 |
4 |
S |
$40.90 |
$265,850 |
D/D |
(6,500) |
117,635 |
0 |
% |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2023-12-15 |
4 |
A |
$25.41 |
$380,820 |
D/D |
14,987 |
132,622 |
0 |
- |
|
ARWR |
Arrowhead Pharmaceuticals... |
Director |
|
2024-01-11 |
4 |
AS |
$37.76 |
$110,788 |
D/D |
(2,911) |
129,711 |
0 |
% |
|
45 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|